Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)

Market Cap	7.62B
Revenue (ttm)	984.51M
Net Income (ttm)	167.21M
Shares Out	319.49M
EPS (ttm)	0.51
PE Ratio	46.87
Forward PE	35.48
Dividend	0.11 (0.46%)
Ex-Dividend Date	Jun 4, 2025

Volume	319,000
Average Volume	723,310
Open	23.86
Previous Close	23.86
Day's Range	23.60 - 24.16
52-Week Range	10.42 - 25.20
Beta	0.49
RSI	61.66
Earnings Date	Aug 15, 2025

About HKG:2190

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cover...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 875
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2190

Financial Performance

Financial numbers in CNY